CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) was previously published as Current Drug Targets-CNS & Neurological Disorders.

Publisher: Bentham Science Publishers

Related content
Volume 10, Number 6, September 2011

< previous issue | all issues | next issue >

Articles

Favourites:Add to Favourites

Targeting Nicotinic Receptors for Parkinson's Disease Therapy
pp. 651-658(8)
Authors: Quik, Maryka; Bordia, Tanuja; Huang, Luping; Perez, Xiomara

Favourites:Add to Favourites

An Update on Adenosine A2A Receptors as Drug Target in Parkinson's Disease
pp. 659-669(11)
Authors: Vallano, Antoni; Fernandez-Duenas, VĂ­ctor; Pedros, Consuelo; Maria Arnau, Josep; Ciruela, Francisco

Favourites:Add to Favourites

The Surgical Management of Parkinson's Disease
pp. 685-692(8)
Authors: A. Ponce, Francisco; M. Lozano, Andres

Favourites:Add to Favourites

Is rTMS an Effective Therapeutic Strategy that Can Be Used to Treat Parkinson's Disease?
pp. 693-702(10)
Authors: Arias-Carrion, Oscar; Machado, Sergio; Paes, Flavia; Velasques, Bruna; Teixeira, Silmar; Cardenas-Morales, Lizbeth; Piedade, Roberto; Ribeiro, Pedro; E. Nardi, Antonio

Favourites:Add to Favourites

GDNF Family Ligands: A Potential Future for Parkinson's Disease Therapy
pp. 703-711(9)
Authors: L. Mickiewicz, Amanda; H. Kordower, Jeffrey

Favourites:Add to Favourites

Drug Targets from Genetics: Alpha-Synuclein
pp. 712-723(12)
Authors: M. Danzer, Karin; J. McLean, Pamela

Favourites:Add to Favourites

Kinases as Targets for Parkinson's Disease: From Genetics to Therapy
pp. 724-740(17)
Authors: Vancraenenbroeck, Renee; Lobbestael, Evy; De Maeyer, Marc; Baekelandt, Veerle; Taymans, Jean-Marc

Favourites:Add to Favourites

Stem Cells in Stroke Repair: Current Success & Future Prospects
pp. 741-756(16)
Authors: Gopurappilly, Renjitha; Pal, Rajarshi; Krishna Mamidi, Murali; Dey, Sovan; Bhonde, Ramesh; Kumar Das, Anjan

Favourites:Add to Favourites

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more